LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 24.81 | 84.90 | 1975 | 1769 | 1.1161 | 1.0508 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 26.51 | 84.90 | 122 | 1923 | 0.0634 | 0.0839 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 26.51 | 84.90 | 2034 | 1923 | 1.0576 | 1.0250 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 26.51 | 84.90 | 157 | 1923 | 0.0816 | 0.1463 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 26.51 | 84.90 | 2100 | 1923 | 1.0919 | 1.0395 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 28.21 | 84.90 | 151 | 2091 | 0.0722 | 0.1327 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 28.21 | 84.90 | 2210 | 2091 | 1.0566 | 1.0240 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 28.21 | 84.90 | 194 | 2091 | 0.0928 | 0.1958 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 28.21 | 84.90 | 2186 | 2091 | 1.0452 | 1.0192 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 29.92 | 84.90 | 199 | 2237 | 0.0889 | 0.1978 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 29.92 | 84.90 | 2366 | 2237 | 1.0573 | 1.0238 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 29.92 | 84.90 | 213 | 2237 | 0.0952 | 0.2152 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 29.92 | 84.90 | 2397 | 2237 | 1.0712 | 1.0293 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 31.62 | 84.90 | 209 | 2449 | 0.0853 | 0.2041 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 31.62 | 84.90 | 2566 | 2449 | 1.0475 | 1.0192 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 31.62 | 84.90 | 222 | 2449 | 0.0906 | 0.2192 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 31.62 | 84.90 | 2591 | 2449 | 1.0577 | 1.0233 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 33.32 | 84.90 | 248 | 2722 | 0.0911 | 0.2390 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 33.32 | 84.90 | 2818 | 2722 | 1.0351 | 1.0138 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 33.32 | 84.90 | 261 | 2722 | 0.0959 | 0.2517 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 33.32 | 84.90 | 2828 | 2722 | 1.0388 | 1.0153 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 35.03 | 84.90 | 252 | 2991 | 0.0842 | 0.2358 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 35.03 | 84.90 | 3079 | 2991 | 1.0293 | 1.0113 | MN20160318_Q02 | L17 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 35.03 | 84.90 | 341 | 2991 | 0.1140 | 0.3107 | MN20160318_Q02 | N15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0010833 | 35.03 | 84.90 | 3082 | 2991 | 1.0303 | 1.0117 | MN20160318_Q02 | N15 |